These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10583701)

  • 1. Digoxin: use pattern in Estonia and bioavailability of the local market leader.
    Pähkla R; Irs A; Oselin K; Rootslane L
    J Clin Pharm Ther; 1999 Oct; 24(5):375-80. PubMed ID: 10583701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
    Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW
    DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative bioavailability study of two tablet formulations of digoxin.
    Aboul-Enein HY; Abou-Basha LI; Wahman LF
    J Immunoassay Immunochem; 2004; 25(2):125-33. PubMed ID: 15162916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of digoxin tablets in healthy volunteers.
    Lee CH; Park YJ; Sands CD; Jones DW; Trang JM
    Arch Pharm Res; 1994 Apr; 17(2):80-6. PubMed ID: 10319136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin bioequivalence study: determination in human plasma by microparticle enzyme immunoassay.
    Borges NC; Guermani A; Mazucheli JA; Mendes GD; Moreno RA
    Int J Clin Pharmacol Ther; 2007 Jun; 45(6):366-72. PubMed ID: 17595894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.
    Ragueneau I; Poirier JM; Radembino N; Sao AB; Funck-Brentano C; Jaillon P
    Br J Clin Pharmacol; 1999 Sep; 48(3):453-6. PubMed ID: 10510161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers.
    Mant T; Fournié P; Ollier C; Donat F; Necciari J
    Clin Pharmacokinet; 2002; 41 Suppl 2():39-45. PubMed ID: 12383044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.
    Zussman BD; Kelly J; Murdoch RD; Clark DJ; Mbchb ; Schubert C; Collie H
    Clin Ther; 2001 Jun; 23(6):921-31. PubMed ID: 11440291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects.
    Vaz da Silva M; Costa R; Soares E; Maia J; Falcão A; Almeida L; Soares da Silva P
    Fundam Clin Pharmacol; 2009 Aug; 23(4):509-14. PubMed ID: 19500154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of an effect of a single-dose deferasirox on the steady-state pharmacokinetics of digoxin.
    Sechaud R; Robeva A; Belleli R; Balez S
    Int J Clin Pharmacol Ther; 2008 Oct; 46(10):519-26. PubMed ID: 18826866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization.
    EL Desoky ES; Nagaraja NV; Derendorf H
    Am J Ther; 2002; 9(6):492-8. PubMed ID: 12424506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
    Verstuyft C; Strabach S; El-Morabet H; Kerb R; Brinkmann U; Dubert L; Jaillon P; Funck-Brentano C; Trugnan G; Becquemont L
    Clin Pharmacol Ther; 2003 Jan; 73(1):51-60. PubMed ID: 12545143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of an interaction between tigecycline and digoxin in healthy men.
    Zimmerman JJ; Harper DM; Matschke K; Speth JL; Raible DG; Fruncillo RJ
    Pharmacotherapy; 2007 Jun; 27(6):835-44. PubMed ID: 17542766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
    Cohen E; Almog S; Staruvin D; Garty M
    Isr Med Assoc J; 2002 Oct; 4(10):772-5. PubMed ID: 12389338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of digoxin in healthy subjects receiving taranabant, a novel cannabinoid-1 receptor inverse agonist.
    Denker AE; Morelli G; Vessey LK; Li S; Yuan J; Dunbar S; Lewis NM; Taggart W; Wagner JA
    Adv Ther; 2009 Feb; 26(2):230-40. PubMed ID: 19219408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady state serum concentrations of pravastatin and digoxin when given in combination.
    Triscari J; Swanson BN; Willard DA; Cohen AI; Devault A; Pan HY
    Br J Clin Pharmacol; 1993 Sep; 36(3):263-5. PubMed ID: 9114914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.